Clinical Trial Update: A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating BTA798 in asthmatic adults with symptomatic human rhinovirus infection has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Rhinovirus Infection

Drugs mentioned

• BTA798

Snippet

Sponsor: Biota Scientific Management Pty Ltd | Conditions: Rhinovirus | Phase 2 | Status: COMPLETED | Results posted: 2017-06-01